Bitterroot Bio to Present Preclinical Research at American Heart Association Conference
PALO ALTO, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Bitterroot Bio, a biotechnology company focused on developing novel immunotherapies in cardiovascular disease, has been selected to present research at the upcoming
Source: benzinga.com